News
A health-care stock that’s maintaining momentum despite regulatory headwinds
Published
8 months agoon
By
admin
(This is a wrap-up of the key money moving discussions on CNBC’s “Worldwide Exchange” exclusive for PRO subscribers. Worldwide Exchange airs at 5 a.m. ET each day.) Investors are looking for opportunities in health care with a focus on recurring revenue. ‘Worldwide Exchange’ Pick: Hims and Hers Health (HIMS) Vance Howard of Howard Capital Management sees more upside in Hims & Hers Health due to its recurring revenue model. “I like things that have recurring revenue,” said Howard. “They have prescription drugs, and people are buying them, and they’re making money each and every month.” Howard also noted the stock has maintained momentum, rising more than 35% over the past month despite receiving a warning letter from the Food and Drug Administration on Sept. 9 about its branding and advertising of weight-loss drugs. Shutdown Impact on the stock market Kourtney Gibson of TIAA said shutdowns don’t generally have a material impact on the market. But, she said, the suspension of the jobs report and potential suspension of the CPI and PPI reports in a prolonged shutdown could have a market impact because the Federal Reserve would not have that data ahead of its meeting in late October. “The question becomes, what will the Fed do? Will they become more dovish and ultimately say we need to cut more or will they actually pause because they are data dependent and they will wait on that data in order to inform the rate cuts for the balance of the year?” said Gibson on Worldwide Exchange, “We’re expecting, around three rate cuts through the balance of the year. Should they not get that (economic data)? Does that put those rate cuts on hold? And ultimately, then the market begin to recalibrate based upon its own data.” ( Learn the best 2026 strategies from inside the NYSE with Josh Brown and others at CNBC PRO Live. Tickets and info here . )
This industrial giant is emerging as a big AI play, says Wells Fargo
Novo Nordisk’s strategy tested as investors push back on board revamp
Alibaba plans AI subscriptions, stablecoin-like payments with JPMorgan
UK borrowing costs spike on report government to scrap plans to raise income tax
Trump’s threatened the BBC with a $1B lawsuit: Here’s what’s going on
UBS’s picks for global returns next year
Wells Fargo sees Caterpillar continuing to roar higher, emerging as an artificial intelligence play. The bank initiated shares of...
Flags with the logos of Danish drugmaker Novo Nordisk, maker of the blockbuster diabetes and weight-loss treatments Ozempic...
Key Points Alibaba plans to use “tokenization” of payments for cross-border transactions in its business-to-business arm. Kuo Zhang, president...
Rachel Reeves, U.K. chancellor of the exchequer, delivers a speech in London, UK, on Tuesday, Nov. 4, 2025. Bloomberg...
US President Donald Trump speaks to reporters as he arrives at Palm Beach International Airport on Oct. 31,...
Investors looking for global diversification opportunities should look to a specific subset of stocks in Europe, according to UBS...
Eakarat Buanoi | Istock | Getty Images LISBON, Portugal — Top tech executives told CNBC they’re concerned about...
Tan Su Shan, deputy chief executive officer and managing director of institutional banking at DBS Group Holdings Ltd., speaks during...
CHENGDU, CHINA – OCTOBER 18: People walk past the Louis Vuitton store at Taikoo Li, a high-end shopping area that...
The United States said Thursday it will remove tariffs on some foods and other imports from Argentina, Ecuador, Guatemala and...
